Stocks and Investing Stocks and Investing
Wed, January 12, 2022
Tue, January 11, 2022
Mon, January 10, 2022
Sun, January 9, 2022
Fri, January 7, 2022

Drew Ranieri Upgraded (TMCI) to Buy and Held Target at $30 on, Jan 7th, 2022


Published on 2024-10-27 19:10:57 - WOPRAI, Drew Ranieri
  Print publication without navigation


Drew Ranieri of Morgan Stanley, Upgraded "Treace Medical Concepts, Inc." (TMCI) to Buy and Held Target at $30 on, Jan 7th, 2022.

Drew has made no other calls on TMCI in the last 4 months.



There is 1 other peer that has a rating on TMCI. Out of the 1 peers that are also analyzing TMCI, 0 agree with Drew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Drew


  • Danielle Antalffy of "SVB Leerink" Maintained at Buy with Decreased Target to $32 on, Friday, November 5th, 2021